Dergiler / Turkish Neurosurgery / 2019 / Cilt: 29 - Sayı: 4

Are Intervertebral Disc Tissue Cells Damaged When Attempting to Prevent Thrombus Formation Using Dabigatran, A New Oral Anticoagulant?

Sayfa
470–477
Yayın Tarihi
2022-11-05
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

No CHAD or MMP-13 expression was noted in these cultures.CONCLUSION: The potential for a systemically applied drug to accumulate in tissue and negatively affect surrounding tissues andmicrostructures must be emphasized.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:AIM: To investigate the effect of dabigatran, a new oral anticoagulant, on human primary cell cultures isolated from intactintervertebral disc tissue.MATERIAL and METHODS: Cell cultures were prepared from tissues obtained from six cases who had undergone surgery dueto spinal trauma.
📊
Temel Bulgular & Veri:Subsequently, chondroadherin (CHAD), cartilageoligomeric matrix protein (COMP), and matrix metalloproteinase (MMP)-13 and -19 expressions were measured via a real-timepolymerase chain reaction (RT-PCR).
💡
Sonuç & Katkı:No CHAD or MMP-13 expression was noted in these cultures.CONCLUSION: The potential for a systemically applied drug to accumulate in tissue and negatively affect surrounding tissues andmicrostructures must be emphasized.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Abstract

AIM: To investigate the effect of dabigatran, a new oral anticoagulant, on human primary cell cultures isolated from intactintervertebral disc tissue.MATERIAL and METHODS: Cell cultures were prepared from tissues obtained from six cases who had undergone surgery dueto spinal trauma. Dabigatran, an active pharmacological agent, was applied to intact annulus fibrosus (AF)/nucleus pulposus (NP)primary cell cultures from the study group. After performing cell viability, toxicity, and proliferation tests on all cultures in the controland study groups, the surface morphologies of the samples were evaluated. Subsequently, chondroadherin (CHAD), cartilageoligomeric matrix protein (COMP), and matrix metalloproteinase (MMP)-13 and -19 expressions were measured via a real-timepolymerase chain reaction (RT-PCR). Data were analyzed statistically.RESULTS: In the proliferation assays performed on the 20th day of the study, cells in the dabigatran-supplemented group werereported to have lost 46.37% more viability than those in the control group. Expressions of all genes examined except MMP-13 wereevaluated in the control group by time, but in contrast to the control group results, COMP and MMP-19 gene expressions decreasedin the dabigatran-treated group. No CHAD or MMP-13 expression was noted in these cultures.CONCLUSION: The potential for a systemically applied drug to accumulate in tissue and negatively affect surrounding tissues andmicrostructures must be emphasized.

🔖

Bu Makaleye Atıf Yap

KAPLAN, N., CALISKAN, T., YILMAZ, I., KARAARSLAN, N., SIRIN, D. Y., AKGUN, F. S., SIMSEK, A. T., OZBEK, H. (2022). Are Intervertebral Disc Tissue Cells Damaged When Attempting to Prevent Thrombus Formation Using Dabigatran, A New Oral Anticoagulant?. Turkish Neurosurgery, Cilt: 29 - Sayı: 4, 470–477. https://ajindex.com/articles/616911

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (1)

  1. Akyuva Y, Kaplan N, Yilmaz I, Ozbek H, Sirin DY, Karaarslan N, Guler O, Ates O: Delivering growth factors through a polymeric scaffold to cell cultures containing both nucleus pulposus and annulus fibrosus. Turk Neurosurg 29(2):180-193, 2019 2. Akyuva Y, Karaarslan N, Yilmaz I, Ozbek H, Sirin DY, Gurbuz MS, Kaya YE, Kaplan N, Ates O: How scaffolds, which are polymeric drug delivery systems allowing controlled release, can be tested in human primary nucleus pulposus and annulus fibrosus cell cultures? Merit Res J Med Med Sci 5:477-487, 2017 3. Bastiaans J, Mulder VC, van Meurs JC, Smits-TeNijenhuis M, van Holten-Neelen C, van Hagen PM, Dik WA: Dabigatran inhibits intravitreal thrombin activity. Acta Ophthalmol 96(5):452-458, 2018 4. Beyer-Westendorf J: What have we learned from real-world NOAC studies in venous thromboembolism treatment? Thromb Res 163:83-91, 2018 5. Briggs MD, Rasmussen IM, Weber JL, Yuen J, Reinker K, Garber AP, Rimoin DL, Cohn DH: Genetic linkage of mild pseudoachondroplasia (PSACH) to markers in the pericentromeric region of chromosome 19. Genomics 18:656- 660, 1993 6. Castle J, Farnie G, Kirwan CC: PO-11 - Thrombin and cancer stem-like cells: In vitro support for breast cancer anticoagulation. Thromb Res 140:80, 2016 7. Chen FH, Herndon ME, Patel N, Hecht JT, Tuan RS, Lawler J: Interaction of cartilage oligomeric matrix protein/ thrombospondin 5 with aggrecan. J Biol Chem 282:24591- 24598, 2007 8. Chu DK, Hillis CM, Leong DP, Anand SS, Siegal DM: Benefits and risks of antithrombotic therapy in essential thrombocythemia: A systematic review. Ann Intern Med 167:170-180, 2017 9. Connolly SJ, Ezekowitz MD, Yusuf S, Eikelboom J, Oldgren J, Parekh A, Pogue J, Reilly PA, et al: Dabigatran versus warfarin in patients with atrial fibrillation. N Engl J Med 361:1139- 11351, 2009 10. Dhar A, Sadiq F, Anstee QM, Levene AP, Goldin RD, Thursz MR: Thrombin and factor Xa link the coagulation system with liver fibrosis. BMC Gastroenterol 18:60, 2018 11. Franchini M, Mannucci PM: Direct oral anticoagulants and venous thromboembolism. Eur Respir Rev 25: 295-302, 2016 12. Goode AP, Marshall SW, Kraus VB, Renner JB, Stürmer T, Carey TS, Irwin DE, Jordan JM: Association between serum and urine biomarkers and lumbar spine individual radiographic features: The Johnston County Osteoarthritis Project. Osteoarthritis Cartilage 20:1286-1293, 2012 13. Gumustas SA, Yilmaz I, Isyar M, Sirin DY, Batmaz AG, Ugras AA, Oznam K, Ciftci Z, Mahirogullari M: Assessing th